Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia

Abstract Background A challenge of understanding the mechanisms underlying cognition including neurodevelopmental and neuropsychiatric disorders is mainly given by the potential severity of cognitive disorders for the quality of life and their prevalence. However, the field has been focused predomin...

Full description

Bibliographic Details
Main Authors: Leonid O. Bryzgalov, Elena E. Korbolina, Ilja I. Brusentsov, Elena Y. Leberfarb, Natalia P. Bondar, Tatiana I. Merkulova
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Neuroscience
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12868-018-0414-3
_version_ 1818965282724511744
author Leonid O. Bryzgalov
Elena E. Korbolina
Ilja I. Brusentsov
Elena Y. Leberfarb
Natalia P. Bondar
Tatiana I. Merkulova
author_facet Leonid O. Bryzgalov
Elena E. Korbolina
Ilja I. Brusentsov
Elena Y. Leberfarb
Natalia P. Bondar
Tatiana I. Merkulova
author_sort Leonid O. Bryzgalov
collection DOAJ
description Abstract Background A challenge of understanding the mechanisms underlying cognition including neurodevelopmental and neuropsychiatric disorders is mainly given by the potential severity of cognitive disorders for the quality of life and their prevalence. However, the field has been focused predominantly on protein coding variation until recently. Given the importance of tightly controlled gene expression for normal brain function, the goal of the study was to assess the functional variation including non-coding variation in human genome that is likely to play an important role in cognitive functions. To this end, we organized and utilized available genome-wide datasets from genomic, transcriptomic and association studies into a comprehensive data corpus. We focused on genomic regions that are enriched in regulatory activity—overlapping transcriptional factor binding regions and repurpose our data collection especially for identification of the regulatory SNPs (rSNPs) that showed associations both with allele-specific binding and allele-specific expression. We matched these rSNPs to the nearby and distant targeted genes and then selected the variants that could implicate the etiology of cognitive disorders according to Genome-Wide Association Studies (GWAS). Next, we use DeSeq 2.0 package to test the differences in the expression of the certain targeted genes between the controls and the patients that were diagnosed bipolar affective disorder and schizophrenia. Finally, we assess the potential biological role for identified drivers of cognition using DAVID and GeneMANIA. Results As a result, we selected fourteen regulatory SNPs locating within the loci, implicated from GWAS for cognitive disorders with six of the variants unreported previously. Grouping of the targeted genes according to biological functions revealed the involvement of processes such as ‘posttranscriptional regulation of gene expression’, ‘neuron differentiation’, ‘neuron projection development’, ‘regulation of cell cycle process’ and ‘protein catabolic processes’. We identified four rSNP-targeted genes that showed differential expression between patient and control groups depending on brain region: NRAS—in schizophrenia cohort, CDC25B, DDX21 and NUCKS1—in bipolar disorder cohort. Conclusions Overall, our findings are likely to provide the keys for unraveling the mechanisms that underlie cognitive functions including major depressive disorder, bipolar disorder and schizophrenia etiopathogenesis.
first_indexed 2024-12-20T13:14:32Z
format Article
id doaj.art-12cbdc1364a0445baf9ef0731b24a273
institution Directory Open Access Journal
issn 1471-2202
language English
last_indexed 2024-12-20T13:14:32Z
publishDate 2018-04-01
publisher BMC
record_format Article
series BMC Neuroscience
spelling doaj.art-12cbdc1364a0445baf9ef0731b24a2732022-12-21T19:39:34ZengBMCBMC Neuroscience1471-22022018-04-0119S1415610.1186/s12868-018-0414-3Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophreniaLeonid O. Bryzgalov0Elena E. Korbolina1Ilja I. Brusentsov2Elena Y. Leberfarb3Natalia P. Bondar4Tatiana I. Merkulova5The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Academy of ScienceThe Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Academy of ScienceThe Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Academy of ScienceThe Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Academy of ScienceThe Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Academy of ScienceThe Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Academy of ScienceAbstract Background A challenge of understanding the mechanisms underlying cognition including neurodevelopmental and neuropsychiatric disorders is mainly given by the potential severity of cognitive disorders for the quality of life and their prevalence. However, the field has been focused predominantly on protein coding variation until recently. Given the importance of tightly controlled gene expression for normal brain function, the goal of the study was to assess the functional variation including non-coding variation in human genome that is likely to play an important role in cognitive functions. To this end, we organized and utilized available genome-wide datasets from genomic, transcriptomic and association studies into a comprehensive data corpus. We focused on genomic regions that are enriched in regulatory activity—overlapping transcriptional factor binding regions and repurpose our data collection especially for identification of the regulatory SNPs (rSNPs) that showed associations both with allele-specific binding and allele-specific expression. We matched these rSNPs to the nearby and distant targeted genes and then selected the variants that could implicate the etiology of cognitive disorders according to Genome-Wide Association Studies (GWAS). Next, we use DeSeq 2.0 package to test the differences in the expression of the certain targeted genes between the controls and the patients that were diagnosed bipolar affective disorder and schizophrenia. Finally, we assess the potential biological role for identified drivers of cognition using DAVID and GeneMANIA. Results As a result, we selected fourteen regulatory SNPs locating within the loci, implicated from GWAS for cognitive disorders with six of the variants unreported previously. Grouping of the targeted genes according to biological functions revealed the involvement of processes such as ‘posttranscriptional regulation of gene expression’, ‘neuron differentiation’, ‘neuron projection development’, ‘regulation of cell cycle process’ and ‘protein catabolic processes’. We identified four rSNP-targeted genes that showed differential expression between patient and control groups depending on brain region: NRAS—in schizophrenia cohort, CDC25B, DDX21 and NUCKS1—in bipolar disorder cohort. Conclusions Overall, our findings are likely to provide the keys for unraveling the mechanisms that underlie cognitive functions including major depressive disorder, bipolar disorder and schizophrenia etiopathogenesis.http://link.springer.com/article/10.1186/s12868-018-0414-3Genetic of cognitionMajor depressive disorderBipolar affective disorderSchizophreniaAutism spectrum disordersSNPs
spellingShingle Leonid O. Bryzgalov
Elena E. Korbolina
Ilja I. Brusentsov
Elena Y. Leberfarb
Natalia P. Bondar
Tatiana I. Merkulova
Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia
BMC Neuroscience
Genetic of cognition
Major depressive disorder
Bipolar affective disorder
Schizophrenia
Autism spectrum disorders
SNPs
title Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia
title_full Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia
title_fullStr Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia
title_full_unstemmed Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia
title_short Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia
title_sort novel functional variants at the gwas implicated loci might confer risk to major depressive disorder bipolar affective disorder and schizophrenia
topic Genetic of cognition
Major depressive disorder
Bipolar affective disorder
Schizophrenia
Autism spectrum disorders
SNPs
url http://link.springer.com/article/10.1186/s12868-018-0414-3
work_keys_str_mv AT leonidobryzgalov novelfunctionalvariantsatthegwasimplicatedlocimightconferrisktomajordepressivedisorderbipolaraffectivedisorderandschizophrenia
AT elenaekorbolina novelfunctionalvariantsatthegwasimplicatedlocimightconferrisktomajordepressivedisorderbipolaraffectivedisorderandschizophrenia
AT iljaibrusentsov novelfunctionalvariantsatthegwasimplicatedlocimightconferrisktomajordepressivedisorderbipolaraffectivedisorderandschizophrenia
AT elenayleberfarb novelfunctionalvariantsatthegwasimplicatedlocimightconferrisktomajordepressivedisorderbipolaraffectivedisorderandschizophrenia
AT nataliapbondar novelfunctionalvariantsatthegwasimplicatedlocimightconferrisktomajordepressivedisorderbipolaraffectivedisorderandschizophrenia
AT tatianaimerkulova novelfunctionalvariantsatthegwasimplicatedlocimightconferrisktomajordepressivedisorderbipolaraffectivedisorderandschizophrenia